APLT Live signals | Maximize Profits with Getagraph.com

BUY 92814 min ago

@ $2.66

Issued: 14 Feb 2024 @ 14:44

Return: 78.20%

Previous signal: Feb 14 - 13:41

Previous signal: Sell

Return: -3.45 %

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 16:00):

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications...

Stats
Today's Volume	720 886
Average Volume	1.86M
Market Cap	541.51M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $-0.0700 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.34
ATR14	$0.0130 (0.27%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-12	Hooks Corwin Dale	Buy	300 000	Common Stock
2024-04-12	Hooks Corwin Dale	Buy	0
2024-03-14	Shendelman Shoshana	Sell	318 573	Common Stock
2024-03-14	Perfetti Riccardo	Sell	110 804	Common Stock
2024-03-14	Hansard Adam	Sell	48 871	Common Stock

INSIDER POWER
42.27
Last 97 transactions
Buy: 24 985 894 \| Sell: 4 549 161

Volume Correlation

Long: -0.44 (neutral)

Short: -0.57 (weak negative)

Signal:(36.301) Neutral

Applied Therapeutics Inc Correlation

10 Most Positive Correlations
NISN	0.932
EYPT	0.926
SEAC	0.906
CYCN	0.901
SCR	0.891
ADMP	0.889
ICON	0.889
WORX	0.889
ACLX	0.889
LEGN	0.886

10 Most Negative Correlations
CHDN	-0.91
REYN	-0.884
SCOR	-0.882
VTRU	-0.881
DCRC	-0.877
SGLB	-0.872
ALGM	-0.866
ENLV	-0.863
MTEX	-0.863
DCGO	-0.862

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Applied Therapeutics Inc Correlation - Currency/Commodity

0.41
( neutral )

0.44
( neutral )

0.00
( neutral )

0.42
( neutral )

0.55
( weak )

-0.62
( weak negative )

Applied Therapeutics Inc Financials

Annual	2023
Revenue:	$9.99M
Gross Profit:	$9.64M (96.47 %)
EPS:	$-1.420

Q4	2023
Revenue:	$-667 000
Gross Profit:	$-1.01M (152.02 %)
EPS:	$-0.450

Q3	2023
Revenue:	$0
Gross Profit:	$-118 000 (0.00 %)
EPS:	$-0.470

Q2	2023
Revenue:	$0
Gross Profit:	$-115 000 (0.00 %)
EPS:	$-0.370

Financial Reports:

No articles found.

Applied Therapeutics Inc

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.